Skip to main content

Publisher: Wiley-Blackwell

Volume 257, Number 1, 1 January 2014

Preview of Immunological Reviews for 2014
pp. 5-5(1)
Author: Koretzky, Gary

Favourites:
ADD

Video podcast: Adoptive Immunotherapy for Cancer
pp. 6-6(1)
Author: Stadanlick, Justina

Favourites:
ADD

Engineering T cells for cancer: our synthetic future
pp. 7-13(7)
Authors: Vonderheide, Robert H.; June, Carl H.

Favourites:
ADD

Adoptive immunotherapy for cancer
pp. 14-38(25)
Authors: Ruella, Marco; Kalos, Michael

Favourites:
ADD

T lymphocytes targeting native receptors
pp. 39-55(17)
Authors: Rooney, Cliona M.; Leen, Ann M.; Vera, Juan F.; Heslop, Helen E.

Favourites:
ADD

Exploiting the curative potential of adoptive T‐cell therapy for cancer
pp. 56-71(16)
Authors: Hinrichs, Christian S.; Rosenberg, Steven A.

Favourites:
ADD

TCR repertoires of intratumoral T‐cell subsets
pp. 72-82(11)
Authors: Linnemann, Carsten; Mezzadra, Riccardo; Schumacher, Ton N. M.

Favourites:
ADD
Favourites:
ADD

CAR T cells: driving the road from the laboratory to the clinic
pp. 91-106(16)
Authors: Cheadle, Eleanor J.; Gornall, Hannah; Baldan, Vania; Hanson, Vivien; Hawkins, Robert E.; Gilham, David E.

Favourites:
ADD

Design and development of therapies using chimeric antigen receptor‐expressing T cells
pp. 107-126(20)
Authors: Dotti, Gianpietro; Gottschalk, Stephen; Savoldo, Barbara; Brenner, Malcolm K.

Favourites:
ADD

Design and implementation of adoptive therapy with chimeric antigen receptor‐modified T cells
pp. 127-144(18)
Authors: Jensen, Michael C.; Riddell, Stanley R.

Favourites:
ADD

Re‐adapting T cells for cancer therapy: from mouse models to clinical trials
pp. 145-164(20)
Authors: Stromnes, Ingunn M.; Schmitt, Thomas M.; Chapuis, Aude G.; Hingorani, Sunil R.; Greenberg, Philip D.

Favourites:
ADD

Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation
pp. 165-180(16)
Authors: Cieri, Nicoletta; Mastaglio, Sara; Oliveira, Giacomo; Casucci, Monica; Bondanza, Attilio; Bonini, Chiara

Favourites:
ADD

A new approach to gene therapy using Sleeping Beauty to genetically modify clinical‐grade T cells to target CD19
pp. 181-190(10)
Authors: Singh, Harjeet; Huls, Helen; Kebriaei, Partow; Cooper, Laurence J. N.

Favourites:
ADD

Human cell‐based artificial antigen‐presenting cells for cancer immunotherapy
pp. 191-209(19)
Authors: Butler, Marcus O.; Hirano, Naoto

Favourites:
ADD

Rapamycin‐resistant effector T‐cell therapy
pp. 210-225(16)
Author: Fowler, Daniel H.

Favourites:
ADD

Genetically engineered donor T cells to optimize graft‐versus‐tumor effects across MHC barriers
pp. 226-236(11)
Authors: Ghosh, Arnab; Holland, Amanda M.; Brink, Marcel R. M.

Favourites:
ADD

Hematopoietic stem cells for cancer immunotherapy
pp. 237-249(13)
Authors: Gschweng, Eric; Oliveira, Satiro; Kohn, Donald B.

Favourites:
ADD

The use of endogenous T cells for adoptive transfer
pp. 250-263(14)
Author: Yee, Cassian

Favourites:
ADD

Uncoupling T‐cell expansion from effector differentiation in cell‐based immunotherapy
pp. 264-276(13)
Authors: Crompton, Joseph G.; Sukumar, Madhusudhanan; Restifo, Nicholas P.

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more